Corporate Governance

Executive Officers

Harry A. Korman
President, North America

Harry A. (Hal) Korman serves Mylan as President, North America. He oversees the growth and development of Mylan Pharmaceuticals Inc. (MPI), Mylan’s generics business in the United States; Genpharm Inc., the former Canadian subsidiary of Merck Generics and fourth largest generics company in Canada; and UDL Laboratories Inc., the U.S. leader in unit dose packaging.

Mr. Korman previously held the positions of President of MPI and Senior Vice President of Mylan Laboratories Inc. Since joining Mylan through its acquisition of UDL Laboratories in 1996, he has served the Company in several capacities of increasing responsibility including President of UDL and Vice President of Sales and Marketing for MPI. He was a Sales Representative for Berlex Laboratories Inc. for approximately eight years.

Mr. Korman earned a bachelor's of science in marketing/distributive education from the University of Wisconsin.

Back to Executive Officers